دورية أكاديمية
Hyaluronan and Its Receptors as Regulatory Molecules of the Endothelial Interface.
| العنوان: | Hyaluronan and Its Receptors as Regulatory Molecules of the Endothelial Interface. |
|---|---|
| المؤلفون: | Queisser KA; Molecular Medicine Program, The University of Utah, Salt Lake City, Utah., Mellema RA; Division of Microbiology & Immunology, Department of Pathology, The University of Utah, Salt Lake City, Utah., Petrey AC; Molecular Medicine Program, The University of Utah, Salt Lake City, Utah.; Division of Microbiology & Immunology, Department of Pathology, The University of Utah, Salt Lake City, Utah. |
| المصدر: | The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society [J Histochem Cytochem] 2021 Jan; Vol. 69 (1), pp. 25-34. Date of Electronic Publication: 2020 Sep 01. |
| نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 9815334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1551-5044 (Electronic) Linking ISSN: 00221554 NLM ISO Abbreviation: J Histochem Cytochem Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2011->: Thousand Oaks, CA : SAGE Publications Original Publication: Baltimore : Williams & Wilkins Co., c1953- |
| مواضيع طبية MeSH: | Endothelial Cells/*metabolism , Glycocalyx/*metabolism , Hyaluronan Receptors/*metabolism , Hyaluronic Acid/*metabolism, Animals ; Humans ; Inflammation/metabolism ; Neovascularization, Physiologic |
| مستخلص: | On the surface of endothelial cells (ECs) lies the glycocalyx, a barrier of polysaccharides that isolates the ECs from the blood. The role of the glycocalyx is dynamic and complex, thanks to not only its structure, but its vast number of components, one being hyaluronan (HA). HA is a critical component of the glycocalyx, having been found to have a wide variety of functions depending on its molecular weight, its modification, and receptor-ligand interactions. As HA and viscous blood are in constant contact, HA can transmit mechanosensory information directly to the cytoskeleton of the ECs. The degradation and synthesis of HA directly alters the permeability of the EC barrier; HA modulation not only alters the physical barrier but also can signal the initiation of other pathways. EC proliferation and angiogenesis are in part regulated by HA fragmentation, HA-dependent receptor binding, and downstream signals. The interaction between the CD44 receptor and HA is a driving force behind leukocyte recruitment, but each class of leukocyte still interacts with HA in unique ways during inflammation. HA regulates a diverse repertoire of EC functions. |
| References: | J Exp Med. 2008 Apr 14;205(4):915-27. (PMID: 18362172) Tissue Barriers. 2013 Jan 1;1(1):. (PMID: 24073386) Blood. 2019 Aug 29;134(9):765-775. (PMID: 31262781) J Biol Chem. 2006 Jul 21;281(29):20303-14. (PMID: 16702221) J Biol Chem. 2002 Feb 15;277(7):4585-8. (PMID: 11717315) Sci Adv. 2020 Mar 11;6(11):eaay0518. (PMID: 32195341) J Biol Chem. 2020 Apr 10;295(15):5036-5050. (PMID: 32034091) J Cell Mol Med. 2009 Sep;13(9B):3463-74. (PMID: 19438808) J Vasc Res. 2007;44(2):87-98. (PMID: 17192719) J Cereb Blood Flow Metab. 2019 Sep;39(9):1759-1775. (PMID: 29589805) J Biol Chem. 2000 Sep 8;275(36):27641-9. (PMID: 10882722) Am J Pathol. 2020 Apr;190(4):791-798. (PMID: 32035882) J Biol Chem. 2006 Nov 10;281(45):34381-93. (PMID: 16963454) J Biol Chem. 2010 Aug 20;285(34):26126-34. (PMID: 20554532) Nat Immunol. 2017 Jul;18(7):762-770. (PMID: 28504698) J Biol Chem. 2004 Apr 23;279(17):17079-84. (PMID: 14764599) Pflugers Arch. 2007 Jun;454(3):345-59. (PMID: 17256154) Exp Physiol. 2011 Sep;96(9):977-86. (PMID: 21551265) Int J Oncol. 2009 Oct;35(4):761-73. (PMID: 19724912) Cells. 2020 Mar 29;9(4):. (PMID: 32235347) Cell. 2015 Apr 23;161(3):486-500. (PMID: 25892224) Biorheology. 2019;56(2-3):77-88. (PMID: 31045510) J Hepatol. 2017 Jan;66(1):228-233. (PMID: 27423427) Nat Med. 2005 Nov;11(11):1173-9. (PMID: 16244651) J Clin Cell Immunol. 2014 Oct 1;5:. (PMID: 27808282) J Biol Chem. 2008 Oct 24;283(43):29602-12. (PMID: 18753140) J Biol Chem. 2014 Feb 28;289(9):5357-70. (PMID: 24425872) Curr Opin Lipidol. 2005 Oct;16(5):507-11. (PMID: 16148534) Fed Proc. 1966 Nov-Dec;25(6):1773-83. (PMID: 5927412) Cell Mol Immunol. 2018 Jul;15(7):663-665. (PMID: 29176746) J Biol Chem. 1996 Sep 27;271(39):23853-64. (PMID: 8798616) J Histochem Cytochem. 2021 Jan;69(1):35-47. (PMID: 32623953) Angiogenesis. 2013 Jul;16(3):689-705. (PMID: 23504212) Circulation. 2010 Nov 30;122(22):2313-22. (PMID: 21098434) J Vasc Res. 2011;48(4):297-306. (PMID: 21273784) J Clin Invest. 1998 Jan 1;101(1):97-108. (PMID: 9421471) Front Immunol. 2014 Mar 11;5:101. (PMID: 24653726) Cell. 2018 Jan 11;172(1-2):305-317.e10. (PMID: 29328918) Oncogene. 2004 Oct 14;23(47):7874-81. (PMID: 15361838) Circ Res. 2003 Apr 4;92(6):592-4. (PMID: 12637366) J Leukoc Biol. 2020 Aug;108(2):705-713. (PMID: 32421905) Clin Rheumatol. 2010 Nov;29(11):1259-67. (PMID: 20552237) Biochim Biophys Acta. 2014 Aug;1840(8):2452-9. (PMID: 24513306) J Biol Chem. 2001 Jun 1;276(22):19420-30. (PMID: 11278811) J Biol Chem. 2016 Nov 18;291(47):24324-24334. (PMID: 27679489) J Intern Med. 2006 Apr;259(4):393-400. (PMID: 16594907) J Investig Med. 2020 Feb;68(2):383-391. (PMID: 31672719) Arch Cardiol Mex. 2013 Oct-Dec;83(4):303-12. (PMID: 24280179) Blood. 2015 Feb 26;125(9):1460-9. (PMID: 25411425) J Cell Biol. 1994 Aug;126(4):1099-109. (PMID: 7519619) J Biol Chem. 2000 May 19;275(20):14939-48. (PMID: 10809739) Circ Res. 2005 Nov 25;97(11):1093-107. (PMID: 16306453) Biochem Biophys Res Commun. 2007 Mar 30;355(1):228-33. (PMID: 17291452) Am J Physiol. 1999 Aug;277(2):H508-14. (PMID: 10444475) Science. 1985 Jun 14;228(4705):1324-6. (PMID: 2408340) J Immunol. 2007 Jul 15;179(2):744-7. (PMID: 17617562) Matrix Biol. 2014 Apr;35:14-7. (PMID: 24486448) Int J Cell Biol. 2015;2015:208303. (PMID: 26448750) J Am Soc Nephrol. 2019 Oct;30(10):1886-1897. (PMID: 31308073) Am J Respir Crit Care Med. 2008 Nov 1;178(9):939-47. (PMID: 18703791) Am J Pathol. 2020 Apr;190(4):742-751. (PMID: 32035881) Biochim Biophys Acta. 2004 Apr 7;1672(1):36-45. (PMID: 15056491) J Biol Chem. 2016 Apr 8;291(15):8014-30. (PMID: 26823460) PLoS One. 2016 Mar 28;11(3):e0152302. (PMID: 27018976) Am J Pathol. 2009 Jun;174(6):2254-64. (PMID: 19443707) Lab Invest. 1998 Aug;78(8):987-1003. (PMID: 9714186) Glycobiology. 2010 Sep;20(9):1117-26. (PMID: 20488939) Biochem J. 1981 Nov 15;200(2):415-24. (PMID: 7340841) Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3261-7. (PMID: 11006212) Inflamm Allergy Drug Targets. 2008 Dec;7(4):224-36. (PMID: 19075788) Int J Cancer. 1997 Apr 10;71(2):251-6. (PMID: 9139851) Br J Clin Pharmacol. 2015 Sep;80(3):389-402. (PMID: 25778676) Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):483-90. (PMID: 20042707) J Biol Chem. 2010 Aug 6;285(32):24639-45. (PMID: 20522558) Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H722-6. (PMID: 12730059) J Biol Chem. 2005 Jun 24;280(25):24195-204. (PMID: 15843382) Antioxid Redox Signal. 2014 Sep 1;21(7):1032-43. (PMID: 24224492) PLoS One. 2013 Nov 18;8(11):e78954. (PMID: 24260138) Am J Respir Cell Mol Biol. 2000 Oct;23(4):444-51. (PMID: 11017908) J Intern Med. 2006 Apr;259(4):339-50. (PMID: 16594902) Curr Med Chem. 2016;23(26):2958-2971. (PMID: 27281127) Clin Transl Sci. 2008 May;1(1):57-61. (PMID: 20443819) Mol Cells. 2012 Jun;33(6):563-74. (PMID: 22610405) J Invest Dermatol. 1994 Oct;103(4):576-9. (PMID: 7523533) Diabetologia. 2008 May;51(5):714-25. (PMID: 18347777) Matrix Biol. 2019 May;78-79:219-235. (PMID: 29425695) Crit Care. 2008;12(4):R102. (PMID: 18691420) Diabetologia. 2010 Dec;53(12):2646-55. (PMID: 20865240) J Struct Biol. 2001 Dec;136(3):239-55. (PMID: 12051903) J Biol Chem. 2001 Sep 28;276(39):36770-8. (PMID: 11448954) Biomacromolecules. 2006 Mar;7(3):659-68. (PMID: 16529395) Scand J Immunol. 1998 Feb;47(2):127-30. (PMID: 9496687) Methods Mol Biol. 2019;1952:1-20. (PMID: 30825161) Microvasc Res. 2010 Dec;80(3):394-401. (PMID: 20600162) |
| معلومات مُعتمدة: | K99 HL135265 United States HL NHLBI NIH HHS; R00 HL135265 United States HL NHLBI NIH HHS |
| فهرسة مساهمة: | Keywords: angiogenesis; extracellular matrix; glycocalyx; glycosaminoglycan; immune cell recruitment; proteoglycan |
| المشرفين على المادة: | 0 (Hyaluronan Receptors) 9004-61-9 (Hyaluronic Acid) |
| تواريخ الأحداث: | Date Created: 20200902 Date Completed: 20210519 Latest Revision: 20231110 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC7780188 |
| DOI: | 10.1369/0022155420954296 |
| PMID: | 32870756 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1551-5044 |
|---|---|
| DOI: | 10.1369/0022155420954296 |